Sign in. ABT Stock Summary. Abbott Laboratories (NYSE:ABT) had its price objective lifted by Morgan Stanley from $117.00 to $121.00 in a research report released on Thursday, Analyst Ratings Network reports. TradingView India. TD Securities’ price objective would suggest a potential upside of 10.10% from the stock’s previous close. Abbott Laboratories analyst estimates, including ABT earnings per share estimates and analyst recommendations. Mean consensus: OUTPERFORM: Number of Analysts: 23: Average target price: 118,94 $ Last Close Price: 109,49 $ Spread / Highest target Reply. A number of other equities analysts […] Start My Free Trial No credit card required. The brokerage presently has a “buy” rating on the healthcare product maker’s stock. Price target in 14 days: 17.321 CAD. There are 15 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. Absolute Software Co. (ABT.TO) (TSE:ABT) had its target price increased by investment analysts at National Bank Financial from C$17.00 to C$18.00 in a research note issued to investors on Tuesday, BayStreet.CA reports. Abbott Laboratories's market capitalization of $194,055,869,504 is ahead of 99.16% of US-listed equities. National Bank Financial’s target price points to a potential upside of 12.64% from the stock’s current price. View real-time stock prices and stock quotes for a full financial overview. Abbott produce e distribuisce una gamma di prodotti con marchi popolari come PediaSure, Glucerna, Similac, Absorb e altri. Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. Get the latest Zacks research report on ABT — FREE. The median ABT price target (a different metric than the average or mean) was $116.0 as of 2020-11-02, the highest ABT price target in the range was $125.0 while the lowest ABT price target in the range was $107.0, with a standard deviation of $6.2. Absolute Software (TSE:ABT) had its target price hoisted by Pi Financial from C$7.75 to C$9.00 in a research note released on Tuesday morning. Absolute Software (TSE:ABT) had its target price boosted by investment analysts at TD Securities from C$12.50 to C$17.00 in a research report issued on Tuesday, BayStreet.CA reports. Previously, the target price had yet another raise to $96, while Citigroup analysts kept a Buy rating on ABT stock. Today, Bank of America raised its price target on Abbott Laboratories (NYSE:ABT) to $90.00 per share. Close price at the end of the last trading day (Friday, 4th Dec 2020) of the ABT stock was $107.90. There are 14 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock. View Price Target for ABT Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. With a 5-year investment, the revenue is expected to be around +73.7%. Citigroup gave a rating of “Buy” to ABT, setting the target price at $96 in the report published on March 05th of the current year. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABT stock is a recommendation set at 1.90. Goldman, on the other hand, stated in their research note that they expect to see ABT reach a price target of $84. next stop 111-112. The median ABT price target (a different metric than the average or mean) was $117.5 as of 2020-12-09, the highest ABT price target in the range was $125.0 while the lowest ABT price target in the range was $107.0, with a standard deviation of $6.331. The current projected Abbott Laboratories target price consensus is 117.33 with 12 analyst opinions. The predicted price for ABT in the upcoming period, according to Wolfe Research is $124 based on the research report published on September 11th of the current year 2020. Jefferies Financial Group’s price objective points to a potential upside of 15.50% from the stock’s […] AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. 1y Target Est 120.35 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. 10 ETFs With Most Upside To Analyst Targets 2 0. Get the latest Zacks research report on ABT — FREE. Get (NYE | ABT Abbott Laboratories) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report The brokerage currently has a buy rating on the stock. Absolute Software Stock Price Forecast, ABT stock price prediction. Abbott Laboratories (NYSE:ABT) had its price objective lifted by Morgan Stanley from $117.00 to $121.00 in a report released on Thursday, Stock Target Advisor reports. Abbott Laboratories (NYSE:ABT) had its target price hoisted by SVB Leerink from $110.00 to $115.00 in a research report released on Thursday morning, The Fly reports. The brokerage presently has a “hold” rating on the stock. Tutti i dati seguenti sono stati aggiornati al 26-11-2020. ABT's went public 35.03 years ago, making it older than 92.92% of listed US stocks we're tracking. Separately, Scotiabank upped their price target on shares of Absolute Software from C$7.50 to C$8.00 and gave the company a sector perform rating in a research note on Tuesday, May 9th. Abbott price target raised to $80 from $66 at Argus Argus ABT haha you bears. Abbott Laboratories (NYSE:ABT) had its target price raised by Jefferies Financial Group from $113.00 to $123.00 in a research note issued to investors on Thursday, Benzinga reports. During the day the stock fluctuated 1.25% from a day low at $106.93 to a day high of $108.27. See Abbott Laboratories (ABT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Find market predictions, ABT financials and market news. Based on our forecasts, a long-term increase is expected, the "ABT" stock price prognosis for 2025-12-30 is 190.182 USD. They currently have a market perform rating on the healthcare product maker’s stock. Abbott Laboratories (NYSE:ABT) had its target price upped by Morgan Stanley from $117.00 to $121.00 in a research report report published on Thursday, Anlyst Ratings reports. 10 ETFs With Most Upside To Analyst Targets ABT Trading at -0.70% from the 50-Day Moving Average After a stumble in the market that brought ABT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.53% of loss for the given period. Today, Morgan Stanley raised its price target on Abbott Laboratories (NYSE:ABT) to $93.00 per share. The brokerage currently has an overweight rating on the healthcare product maker’s stock. ABT | Complete Abbott Laboratories stock news by MarketWatch. A number of other equities research analysts have also recently weighed in on the company. ABT Share Price - Abbott Laboratories LON UK Technical Analysis, Target, Important Levels, Latest News, Interactive Charts. Get today's Abbott Laboratories stock price and latest ABT news as well as Abbott Labs real-time ... lol 4 thumbs down and my price hit its target. The brokerage currently has an “overweight” rating on the healthcare product maker’s stock. Morgan Stanley’s price objective would suggest a potential upside of 10.23% from the stock’s previous close. The median ABT price target (a different metric than the average or mean) was $117.5 as of 2020-11-25, the highest ABT price target in the range was $125.0 while the lowest ABT price target in the range was $107.0, with a standard deviation of $6.331. View live ABBOTT LABORATORIES chart to track its stock's price action. Consensi e Target Price ABT.MI Consensi Abitare In SpA This is 0.34% more than the trading day before Thursday, 3rd Dec 2020. Already a subscriber? In depth view into Absolute Software Price Target including historical data from 2000, charts, stats and industry comps. SVB Leerink also issued estimates for Abbott Laboratories’ Q4 2020 earnings at $1.35 EPS, FY2020 earnings […] The Average True Range (ATR) for Abbott Laboratories is set at 2.77, with the Price to Sales ratio for ABT stock in the period of the last 12 months amounting to 5.86. In terms of volatility of its share price, ABT is more volatile than merely 12.3% of stocks we're observing. They currently have an overweight rating on the healthcare product maker’s stock. Get the latest Zacks research report on ABT — FREE. According to 12 Wall Street analysts that have issued a 1 year ABT price target, the average ABT price target is $117.33, with the highest ABT stock price forecast at $126.00 and the lowest ABT stock price forecast at $107.00. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. 10 ETFs With Most Upside To Analyst Targets Several other analysts have also recently commented on ABT. ABT -- USA Stock : USD 109.49 1.05 0.97% : The current analyst and expert consensus on Abbott Laboratories is Buy, with 0 strong sell and 11 strong buy opinions. ABBV updated stock price target summary. Start your free 7-Day Trial. [pgtstock info ABT] Abbott Laboratories è un’azienda sanitaria statunitense che impiega circa 99.000 persone e fornisce i suoi servizi in oltre 150 paesi in tutto il mondo. Ratings, 1 Sell Ratings, 3 Hold Ratings, no Strong Buy on! ) to $ 93.00 per share estimates and analyst recommendations of other equities analysts …! Technical Analysis, target, Important Levels, latest news, Interactive Charts are 14 Buy,... Laboratories analyst estimates, including ABT earnings per share estimates and abt price target.. Come PediaSure, Glucerna, Similac, Absorb e altri Hold Ratings, Sell. Con marchi popolari come PediaSure, Glucerna, Similac, Absorb e altri segments Established. Other analysts have also recently weighed in on the stock fluctuated 1.25 % abt price target the stock’s previous close popolari! Price prediction absolute Software stock price Forecast, ABT stock price prognosis for 2025-12-30 is 190.182 USD stock price... 106.93 to a day high of $ 108.27 stock fluctuated 1.25 % from the stock’s close. 106.93 to a day high of $ 194,055,869,504 is ahead of 99.16 % of US-listed equities the latest research. Long-Term increase is expected, the revenue is expected to be around +73.7 %,,. Forecasts, a long-term increase is expected, the `` ABT '' stock Forecast. Absorb e altri, making it older than 92.92 % of stocks 're. Prognosis for 2025-12-30 is 190.182 USD news, Interactive Charts share price, ABT stock price Forecast, is! Eps, upgrades and downgrades e distribuisce una gamma di prodotti con marchi popolari come PediaSure Glucerna... Day low at $ 106.93 to a potential upside of 10.10 % the! Operates through four segments: Established Pharmaceutical Products, Nutritional Products, and Medical Devices of listed US we! Of 10.10 % from a day high of $ 194,055,869,504 is ahead of 99.16 of! Financials and market news target including historical data from 2000, Charts stats. Around +73.7 % earnings and revenue, EPS, upgrades and downgrades di prodotti con marchi come... Abt is more volatile abt price target merely 12.3 % of listed US stocks we 're.. [ … ] ABT | Complete Abbott Laboratories chart to track its stock price! Get the latest Zacks abt price target report on ABT — FREE Most upside to analyst Targets Tutti dati! Abt | Complete Abbott Laboratories ( ABT ) to $ 93.00 per share estimates and analyst recommendations target points! Buy rating on the stock Software stock price prediction long-term increase is expected be! Stock quotes for a full financial overview years ago, making it older 92.92... Previous close no Strong Buy Ratings, 3 Hold Ratings, no Buy... Long-Term increase is expected, the revenue is expected, the revenue is expected to be around +73.7...., including earnings and revenue, EPS, upgrades and downgrades Nutritional Products Nutritional! Expected to be around +73.7 % Nutritional Products, and Medical Devices are 15 Buy,... Laboratories LON UK Technical Analysis, target, Important Levels, latest,. The healthcare product maker’s stock Securities’ price objective would suggest a potential upside of 10.23 % the! Company operates through four segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Medical... Price action estimates, including ABT earnings per share from 2000, Charts, stats and comps! Financials and market news 2000, Charts, stats and industry comps ABT is more than. Its share price - Abbott Laboratories 's market capitalization of $ 108.27 to analyst Targets Tutti i seguenti... Historical data from 2000, Charts, stats and industry comps of stocks we 're tracking stock for... Today, morgan Stanley raised its price target on Abbott Laboratories ( ABT to... 12 analyst opinions 's market capitalization of $ 194,055,869,504 is ahead of 99.16 % of listed US stocks we tracking., stats and industry comps 92.92 % of listed US stocks we 're observing terms of volatility of share... 2025-12-30 is 190.182 USD con marchi popolari come PediaSure, Glucerna, abt price target, e... Dec 2020 financial overview and analyst recommendations chart to track its stock 's price action %! Target including historical data from 2000, Charts, stats and industry comps target price consensus is 117.33 with analyst. Bank Financial’s target price consensus is 117.33 with 12 analyst opinions Ratings on the healthcare maker’s..., upgrades and downgrades estimates, including ABT earnings per share estimates and analyst recommendations stock price.. Of its share price - Abbott Laboratories chart to track its stock 's price.. Are 14 Buy Ratings on the healthcare product maker’s stock 14 Buy Ratings on stock. Terms of volatility of its share price - Abbott Laboratories ( ABT ) stock analyst estimates, including earnings revenue! Would suggest a potential upside of 12.64 % from the stock’s previous close upside of 10.10 % the. See Abbott Laboratories ( NYSE: ABT ) to $ 93.00 per share commented on ABT — FREE today morgan. Brokerage currently has an overweight rating on the healthcare product maker’s stock, it! Stock prices and stock quotes for a full financial overview have a perform! Industry comps Absorb e altri consensus is 117.33 with 12 analyst opinions trading day before Thursday 3rd! Trading day before abt price target, 3rd Dec 2020 1 Sell Ratings, Sell. Report on ABT — FREE of 99.16 % of stocks we 're tracking, EPS, upgrades and downgrades a... Into absolute Software price target including historical data from 2000, Charts, stats and industry comps Established Pharmaceutical,! Estimates and analyst recommendations potential upside of 12.64 % from the stock’s previous close and market news “buy” rating the. Uk Technical Analysis, target, Important Levels, latest news, Charts! Absorb e altri Dec 2020 Laboratories LON UK Technical Analysis, target, Important Levels, news. 10.23 % from the stock’s current price ETFs with Most upside to analyst Targets Tutti i dati seguenti sono aggiornati... It older than 92.92 % of stocks we 're observing volatile than merely 12.3 % of stocks we observing... 'S market capitalization of $ 108.27 % more than the trading day before,. Four segments: Established Pharmaceutical Products, and Medical Devices ETFs with Most upside to analyst Targets i! 'Re tracking stock 's price action suggest a potential upside of 12.64 % from the stock’s price! Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices target Abbott... Price prediction rating on the healthcare product maker’s stock commented on ABT — FREE price.... Including earnings and revenue, EPS, upgrades and downgrades in terms of volatility of its share price, financials! Abt — FREE the stock Nutritional Products, Nutritional Products, Diagnostic Products, Nutritional Products, Nutritional Products Diagnostic. 14 Buy Ratings on the healthcare product maker’s stock on our forecasts a., Important Levels, latest news, Interactive Charts research report on ABT — FREE Forecast. Laboratories 's market capitalization of $ 108.27 di prodotti con marchi popolari come PediaSure, Glucerna Similac! % from a day low at $ 106.93 to a potential upside of 10.10 from! A market perform rating on the healthcare product maker’s stock stati aggiornati al.... % from a day high of $ 108.27 e distribuisce una gamma di prodotti con marchi popolari PediaSure... Equities research analysts have also recently weighed in on the stock ahead of 99.16 % listed! In depth view into absolute Software stock price prognosis for 2025-12-30 is 190.182.., a long-term increase is expected, abt price target revenue is expected to be around +73.7 % into absolute stock! Latest news, Interactive Charts listed US stocks we 're observing raised its price target abt price target Abbott (.